TransMedics Group Inc.

TransMedics Group Inc. is a medical technology company specializing in advanced organ transplant therapies for patients suffering from end-stage organ failure. Its primary innovation, the Organ Care System (OCS), is a portable, proprietary platform designed to preserve, assess, and transport donor organs—including lungs, hearts, and livers—by replicating near-physiologic conditions outside the human body. This technology significantly improves organ viability compared to traditional cold storage, aiming to expand the pool of transplantable organs and enhance recipient outcomes. In addition to its core OCS products, TransMedics offers comprehensive clinical service solutions such as the National OCS Program, which provides outsourced organ retrieval, management, and logistics—including both aviation and ground transport coordination. These integrated offerings help transplant centers increase organ transplant volume, streamline logistics, and optimize clinical resources. TransMedics plays a pivotal role in the healthcare sector by redefining standards in organ transplantation and supporting medical institutions globally with innovative, end-to-end solutions for organ management and transplantation procedures.